Physician profile
Jeffrey Lin
NPI 1730613308
$1,095.35
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.66 · 2021: $16.67 · 2022: $456 · 2023: $352 · 2024: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $290.79 | 2021-2024 | |
| Gilead Sciences, INC. | $193.92 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $121.22 | 2022 | |
| Stryker Corporation | $94.94 | 2024 | Mild Device Kit |
| Mylan Specialty L.P. | $77.93 | 2023-2024 | Yupelri |
| Viiv Healthcare Company | $63.57 | 2023 | Apretude |
| Novo Nordisk INC | $56.03 | 2023-2024 | Ozempic, Rybelsus |
| Hologic Sales and Service, LLC | $48.37 | 2022-2023 | Aptima, Thinprep 2000 Processor, Third Wave |
| Sobi, INC | $25.66 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.66 | 2019 | |
| Abbott Laboratories | $21.89 | 2023 | Eterna |
| Sanofi Pasteur INC. | $21.61 | 2022 | |
| Organon LLC | $21.02 | 2023 | Nexplanon |
| Exeltis, USA INC. | $19.90 | 2023 | Slynd |
| Exact Sciences Corporation | $13.84 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.